Complementary Alternative Cardiovascular Medicine

70 Alternative Cardiovascular Medicine
38. Pullin CH, Ashfield-Watt PA, Burr ML, et al. Optimization of dietary folate or low
dose folic acid supplements lower homocysteine but do not enhance endothelial
function in healthy adults, irrespective of the methylenetetrahydrofolate reductase
(C677T) genotype. J Am Coll Cardiol 2001;38:1799–1805.
39. Nakano E, Higgins JA, Powers HJ. Short communication. Folate protects against
oxidative modification of human LDL. Br J Nutr 2001;86:637–639.
40. Schnyder G, Roffi M, Pin R, et al. Decreased rate of coronary restenosis with
lowering of plasma homocysteine levels. N Engl J Med 2001;345:1593–1600.
41. Schnyder G, Roffi M, Flammer Y, et al. Effect of homocysteine-lowering therapy
with folic acid, vitamin B 12 and vitamin B 6 on clinical outcome after percutaneous
coronary intervention. JAMA 2002;288:973–979.
42. Genser D, Pracher H, Hauer R, et al. Relation of homocysteine, vitamin B 12 and
folate to coronary in-stent restenosis. Am J Cardiol 2002;89:495–499.
43. Brown AA, Hu FB. Dietary modulation of endothelial function: implications for
cardiovascular disease. Am J Clin Nutr 2001;73:673–686.
44. Katz DL, Nawaz H, Boukhalil J, et al. Acute effects of oats and vitamin E on
endothelial responses to ingested fat. Am J Prev Med 2001;20:124–129.
45. Chambers JC, McGregor A, Jean-Marie J, Obeid OA, Kooner JS. Demonstration of
rapid onset vascular endothelial function after hyperhomocysteinemia: an effect
reversible with vitamin C therapy. Circulation 1999;99:1156–1160.
46. Skyrme-Jones RA, O’Brien OC, Berry KL, Meredith IT. Vitamin E supplementation
improves endothelial function in type 1 diabetes mellitus: a randomized, placebo-controlled
study. J Am Coll Cardiol 2000;36:94–102.
47. Kugiyama K, Motoyama T, Doi H, et al. Improvement of endothelial vasomotor
dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoprotein
levels. J Am Coll Cardiol 1999;33:1512–1518.
48. Richartz BM, Werner GS, Ferrari M, Figulla HR. Reversibility of coronary endothelial
vasomotor dysfunction in idiopathic dilated cardiomyopathy; acute effects of
vitamin C. Am J Cardiol 2001;88:10001–1005.
49. Rossig L, Hoffmann J, Hugel B, et al. Vitamin C inhibits endothelial cell apoptosis
in congestive heart failure. Circulation 2001;104:2181–2187.
50. Fang JC, Kinlay S, Beltrame J, et al. Effect of vitamins C and E on Progression of
transplant associated arteriosclerosis: a randomized trial. Lancet 2002;359:1108–1113.
51. McKechnie R, Rubenfire M, Mosca L. Antioxidant nutrient supplementation and
brachial reactivity in patients with coronary artery disease. Lab Clin Med
2002;139;133–139.
52. Canner PL, Berge KG,Winger NK, et al. Fifteen year mortality in Coronary Drug
Project patients: long term benefits with niacin. J Am Coll Cardiol 1986;8:1245–1255.
53. Schectman G, Hiatt A. Evaluation of the effectiveness of lipid lowering therapy
(bile acid sequestrants, niacin, psyllium and lovastatin) for treating hypercholesterolemia
in veterans. Am J Cardiol 1993;71:758–765.
54. Ellingworth DR, Stein EA, Mitchell YB, et al. Comparative effects of lovastatin and
niacin in primary hypercholesterolemia: a prospective trial. Arch Intern Med
1994;154:1586–1595.
55. Davignon J, Raederer G, Montigny M, et al. Comparative efficacy and safety of
pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia.
Am J Cardiol 1994;73:339–345.
56. Jokubaitis LA. Fluvastatin in combination and other lipid-lowering agents. Br J Clin
Pract 1996;77A(suppl):28–32.
57. Jacobson TA, Chin MM, Fromel GJ, Jokubaitis LA, Amorosa LF. Fluvastatin with
and without niacin for hypercholesterolemia. Am J Cardiol 1994;74:149–154.